Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Neurological and Neurophysiological Findings in Workers with Chronic 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Intoxication 50 Years After Exposure

D. Pelclova, P. Urban, Z. Fenclova, S. Vlckova, P. Ridzon, K. Kupka, Z. Meckova, O. Bezdicek, T. Navratil, J. Rosmus, S. Zakharov,

. 2018 ; 122 (2) : 271-277. [pub] 20170927

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033748

The last eight survivors of 80 workers accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) during production of herbicides based on trichlorophenoxyacetic acid in 1965-1967 in a chemical factory were followed. All were men, mean age 72.4 ± 1.3 years. Their current median TCDD blood level was 112 (46-390) pg/g lipids. Neurological examination revealed central nervous system impairment in all individuals and signs of polyneuropathy in 87.5%, which was confirmed by a nerve conduction study (NCS) in 75%. A Lanthony test demonstrated acquired dyschromatopsia in 87.5% of the patients, with deterioration of mean colour confusion index (CCI) from 1.52 ± 0.39 in 2010 to 1.73 ± 0.41 in 2016. Single-photon emission computer tomography (SPECT) of the brain showed focal reduction of perfusion in various brain locations in all patients and worsening in six patients. Visual-evoked potentials (VEP) was abnormal in 62.6% of individuals. Most patients complained of psychological problems. The neuropsychological test battery showed most positive impairments in the Trail Making Test evaluating processing speed (average level in the range of mild neurocognitive impairment), which correlated with mean CCI (p < 0.05). CONCLUSION: Fifty years after exposure, blood levels of TCDD are still 10 times higher than the general population. NCS, VEP, Lanthony test and SPECT findings deteriorated from examination of these patients in 2004 and in 2010. The total of abnormal tests per patient in 2016 is very high. Minor differences among patients and their reduced count may explain why the number of impairments in 2016 does not correlate with TCDD blood level.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033748
003      
CZ-PrNML
005      
20250403084319.0
007      
ta
008      
181008s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bcpt.12899 $2 doi
035    __
$a (PubMed)28862800
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pelclova, Daniela $u Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
245    10
$a Neurological and Neurophysiological Findings in Workers with Chronic 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Intoxication 50 Years After Exposure / $c D. Pelclova, P. Urban, Z. Fenclova, S. Vlckova, P. Ridzon, K. Kupka, Z. Meckova, O. Bezdicek, T. Navratil, J. Rosmus, S. Zakharov,
520    9_
$a The last eight survivors of 80 workers accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) during production of herbicides based on trichlorophenoxyacetic acid in 1965-1967 in a chemical factory were followed. All were men, mean age 72.4 ± 1.3 years. Their current median TCDD blood level was 112 (46-390) pg/g lipids. Neurological examination revealed central nervous system impairment in all individuals and signs of polyneuropathy in 87.5%, which was confirmed by a nerve conduction study (NCS) in 75%. A Lanthony test demonstrated acquired dyschromatopsia in 87.5% of the patients, with deterioration of mean colour confusion index (CCI) from 1.52 ± 0.39 in 2010 to 1.73 ± 0.41 in 2016. Single-photon emission computer tomography (SPECT) of the brain showed focal reduction of perfusion in various brain locations in all patients and worsening in six patients. Visual-evoked potentials (VEP) was abnormal in 62.6% of individuals. Most patients complained of psychological problems. The neuropsychological test battery showed most positive impairments in the Trail Making Test evaluating processing speed (average level in the range of mild neurocognitive impairment), which correlated with mean CCI (p < 0.05). CONCLUSION: Fifty years after exposure, blood levels of TCDD are still 10 times higher than the general population. NCS, VEP, Lanthony test and SPECT findings deteriorated from examination of these patients in 2004 and in 2010. The total of abnormal tests per patient in 2016 is very high. Minor differences among patients and their reduced count may explain why the number of impairments in 2016 does not correlate with TCDD blood level.
650    12
$a pracovní nehody $7 D000062
650    _2
$a senioři $7 D000368
650    _2
$a mozek $x diagnostické zobrazování $x účinky léků $x patofyziologie $7 D001921
650    _2
$a mozkový krevní oběh $x účinky léků $7 D002560
650    12
$a chemický průmysl $7 D002617
650    _2
$a kognice $x účinky léků $7 D003071
650    _2
$a vidění barevné $x účinky léků $7 D055253
650    _2
$a zrakové evokované potenciály $x účinky léků $7 D005074
650    _2
$a herbicidy $x škodlivé účinky $x krev $x chemická syntéza $7 D006540
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nervové vedení $x účinky léků $7 D009431
650    _2
$a neurologické vyšetření $7 D009460
650    _2
$a neuropsychologické testy $7 D009483
650    _2
$a neurotoxické syndromy $x diagnóza $x etiologie $x patofyziologie $x psychologie $7 D020258
650    _2
$a pracovní expozice $x škodlivé účinky $7 D016273
650    12
$a hygiena práce $7 D016272
650    _2
$a perfuzní zobrazování $x metody $7 D055420
650    _2
$a polychlorované dibenzodioxiny $x škodlivé účinky $x krev $x chemická syntéza $7 D000072317
650    _2
$a polyneuropatie $x chemicky indukované $x diagnóza $x patofyziologie $7 D011115
650    _2
$a časové faktory $7 D013997
650    _2
$a jednofotonová emisní výpočetní tomografie $7 D015899
655    _2
$a časopisecké články $7 D016428
700    1_
$a Urban, Pavel $u Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. National Institute of Public Health, Prague, Czech Republic.
700    1_
$a Fenclová, Zdeňka, $d 1958- $u Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. $7 xx0074215
700    1_
$a Vlckova, Stepanka $u Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Ridzon, Petr $u Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Kupka, Karel $u Institute of Nuclear Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Meckova, Zuzana $u Institute of Nuclear Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Bezdicek, Ondrej $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Navratil, Tomas $u J. Heyrovsky Institute of Physical Chemistry of the CAS, v.v.i., Prague, Czech Republic. Institute of Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Rosmus, Jan $u State Veterinary Institute Prague, Chemistry, Czech Republic.
700    1_
$a Zakharov, Sergey $u Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
773    0_
$w MED00007578 $t Basic & clinical pharmacology & toxicology $x 1742-7843 $g Roč. 122, č. 2 (2018), s. 271-277
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28862800 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20250403084314 $b ABA008
999    __
$a ok $b bmc $g 1340276 $s 1030742
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 122 $c 2 $d 271-277 $e 20170927 $i 1742-7843 $m Basic & clinical pharmacology & toxicology $n Basic Clin Pharmacol Toxicol $x MED00007578
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace